VRDN
Viridian Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.92
−0.17%Margins
Gross margin
99.6%
EBITDA margin
-517.4%
EBIT margin
-569.7%
Net margin
-544.1%
FCF margin
-471.0%
-58.4%
Return on equity
-35.3%
Return on assets
-44.8%
Return on invested capital
0.08x
Asset turnover
-$333.3M
Cash from operations
$8.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026